<?xml version="1.0" encoding="UTF-8"?>
<ref id="B48-pharmaceuticals-12-00060">
 <label>48.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bayer</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Lennemann</surname>
    <given-names>N.J.</given-names>
   </name>
   <name>
    <surname>Ouyang</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Bramley</surname>
    <given-names>J.C.</given-names>
   </name>
   <name>
    <surname>Morosky</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Marques</surname>
    <given-names>E.T.D.A.</given-names>
   </name>
   <name>
    <surname>Cherry</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Sadovsky</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Coyne</surname>
    <given-names>C.B.</given-names>
   </name>
   <name>
    <surname>Coyne</surname>
    <given-names>C.B.</given-names>
   </name>
  </person-group>
  <article-title>Type III Interferons Produced by Human Placental Trophoblasts Confer Protection against Zika Virus Infection</article-title>
  <source>Cell Host Microbe</source>
  <year>2016</year>
  <volume>19</volume>
  <fpage>705</fpage>
  <lpage>712</lpage>
  <pub-id pub-id-type="doi">10.1016/j.chom.2016.03.008</pub-id>
  <pub-id pub-id-type="pmid">27066743</pub-id>
 </element-citation>
</ref>
